Tracking outcomes of islet transplants for diabetes treatment
Official title: Continuation of The Collaborative Islet Transplantation Registry (CITR)
Funded at The Emmes Company, LLC · NIH-10903933 · Data updated 2026-11-12
This study is looking at how well pancreatic islet transplants work for people with Type 1 diabetes who have trouble managing their blood sugar, so we can learn more about how to help them feel better and stay healthier.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | September 15, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $314,470 |
| NIH project number | 5U01DK133709-03 |
| Project ID | NIH-10903933 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with Type 1 diabetes who have severe glycemic lability and may benefit from islet transplantation.
✕Less likely to help
Patients who do not have Type 1 diabetes or those who are not candidates for islet transplantation may not receive benefits from this research.
What this research studies
This research focuses on the Collaborative Islet Transplantation Registry, which collects and analyzes data on both allogeneic and autologous pancreatic islet transplants. The goal is to monitor the effectiveness and safety of these transplants in patients with Type 1 diabetes who experience severe blood sugar fluctuations. By collaborating with various stakeholders, the study aims to improve understanding of how these transplants can help patients regain better glycemic control. Patients' experiences and outcomes will be systematically documented to enhance future treatment approaches.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better management of diabetes for patients undergoing islet transplantation.
How similar studies have gone: Previous research on islet transplantation has shown promising results in improving glycemic control for patients with Type 1 diabetes, indicating that this approach has a foundation of success.
Where this research is happening
-
The Emmes Company, LLC
Rockville, United States Active
Researchers
- Principal investigator: Payne, Elizabeth Holly — The Emmes Company, LLC
- Study coordinator: Payne, Elizabeth Holly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.